News Sentiment

TEVA sentiment intelligence

Teva Pharmaceutical Industries Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 12 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 29.00 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

89/100 classification confidence.

Company focus 12

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-4.0% over one week, -1.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Consensus Rating of "Moderate Buy" by Brokerages

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 89/100 classification
One-week reaction -4.0% Price reacting lower
Trend fit Trend active -1.4% over four weeks
Fair value 71.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 9
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 12
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 6
MarketBeat 2
marketscreener.com 2
Stocktwits 1
simplywall.st 1

Event Lens

What the news is about

Classified themes
Market update 10
Analyst action 1
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-12 of 12